This invention provides a compound selected from the group consisting of L- nicotine(X1)(X2) and D-nicotine(X1)(X2), or a pharmaceutically acceptable salt thereof, wherein (i) each of Χ1 and X2 is independently a pharmaceutically acceptable anion or a null set; and (ii) Χ1 and X2 cannot both be null sets. This invention also provides related compositions, as well as methods for treating a disorder reasonably believed to be ameliorated by the administration of nicotine.
本发明提供了一种化合物,所选自组中包括L-
尼古丁(X1)(X2)和D-
尼古丁(X1)(X2),或其药学上可接受的盐,其中(i)Χ1和X2各自独立地是药学上可接受的阴离子或空集;(ii)Χ1和X2不能同时为空集。本发明还提供了相关的组合物,以及治疗通过
尼古丁治疗合理地认为能够改善的疾病的方法。